MRKR — Marker Therapeutics, Inc.

MRKRMarker Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · markertherapeutics.com

1.430USD+2.14%Mkt Cap: 23.76M USDP/E: —Last update: 2026-05-26

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United Stat…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap23.76M USD

Enterprise Value8.93M USD

Revenue (TTM)3.55M USD

Gross Profit-8.25M USD

Net Income (TTM)-12.16M USD

Revenue/Share0.2040 USD

Last Price1.430 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees5

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS57055L2060

Valuation

P/E (Trailing)—

P/E (Forward)-8.41

PEG—

EV/EBITDA—

EV/Revenue2.52

P/S6.72

P/B1.73

EPS (TTM)-0.55

EPS (Forward)-0.17

52W Range

0.810019% of range4.070

52W High4.070 USD

52W Low0.8100 USD

Profitability

Gross Margin-232.68%

Oper. Margin-338.49%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-72.42%

ROA-63.78%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-12.01M USD

CapEx (TTM)—

FCF Margin-142.32%

FCF Yield-21.24%

Net Debt-14.92M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio4.79

Quick Ratio4.48

Book Value/Sh0.8260 USD

Cash/Share0.8950 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateSep 16, 2016

Splits

Last Split1:10

Split DateJan 27, 2023

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)7.867 USD

Target Range5.600 USD – 10.00 USD

# Analysts3

Ownership

Shares Out.16.67M

Float13.81M

Insiders5.49%

Institutions24.29%

Short Interest

Short Ratio1.1d

Short % Float1.12%

Short % Out.0.90%

Shares Short150.56K

Short (prev mo.)512.68K

Technical

SMA 501.445 (-1.0%)

SMA 2001.315 (+8.7%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)73.75K

Avg Vol (10d)52.45K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—